EP2068628A4 - Procédé de traitement d'une affection associée a la phosphorylation de task-i - Google Patents

Procédé de traitement d'une affection associée a la phosphorylation de task-i

Info

Publication number
EP2068628A4
EP2068628A4 EP07836321A EP07836321A EP2068628A4 EP 2068628 A4 EP2068628 A4 EP 2068628A4 EP 07836321 A EP07836321 A EP 07836321A EP 07836321 A EP07836321 A EP 07836321A EP 2068628 A4 EP2068628 A4 EP 2068628A4
Authority
EP
European Patent Office
Prior art keywords
phosphorylation
task
treating
condition associated
condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07836321A
Other languages
German (de)
English (en)
Other versions
EP2068628A2 (fr
Inventor
Steven J Feinmark
Richard B Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Original Assignee
Columbia University in the City of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/029544 external-priority patent/WO2007014347A2/fr
Priority claimed from US11/498,343 external-priority patent/US8097650B2/en
Application filed by Columbia University in the City of New York filed Critical Columbia University in the City of New York
Publication of EP2068628A2 publication Critical patent/EP2068628A2/fr
Publication of EP2068628A4 publication Critical patent/EP2068628A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP07836321A 2006-07-27 2007-07-27 Procédé de traitement d'une affection associée a la phosphorylation de task-i Withdrawn EP2068628A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2006/029544 WO2007014347A2 (fr) 2005-07-27 2006-07-27 Methode de traitement d'etats pathologiques associes a la phosphorylation du canal task-1
US11/498,343 US8097650B2 (en) 2005-07-27 2006-08-02 Method of treating a condition associated with phosphorylation of TASK-1
PCT/US2007/016999 WO2008013988A2 (fr) 2006-07-27 2007-07-27 Procédé de traitement d'une affection associée a la phosphorylation de task-i

Publications (2)

Publication Number Publication Date
EP2068628A2 EP2068628A2 (fr) 2009-06-17
EP2068628A4 true EP2068628A4 (fr) 2009-11-04

Family

ID=38982134

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07836321A Withdrawn EP2068628A4 (fr) 2006-07-27 2007-07-27 Procédé de traitement d'une affection associée a la phosphorylation de task-i

Country Status (2)

Country Link
EP (1) EP2068628A4 (fr)
WO (1) WO2008013988A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001097798A1 (fr) * 2000-06-16 2001-12-27 Smithkline Beecham Corporation Procede servant a prevenir ou a reduire des evenements cardio-vasculaires induits par intervention coronarienne
DE10332685A1 (de) * 2003-07-18 2005-02-17 Bayer Healthcare Ag Vorhof-selektiv exprimierte Kaliumkanäle
WO2007014347A2 (fr) * 2005-07-27 2007-02-01 The Trustees Of Columbia University In The City Of New York Methode de traitement d'etats pathologiques associes a la phosphorylation du canal task-1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1051485A1 (fr) * 1998-01-27 2000-11-15 Smithkline Beecham Plc Canal potassium a deux pores semblable a trek-1

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001097798A1 (fr) * 2000-06-16 2001-12-27 Smithkline Beecham Corporation Procede servant a prevenir ou a reduire des evenements cardio-vasculaires induits par intervention coronarienne
DE10332685A1 (de) * 2003-07-18 2005-02-17 Bayer Healthcare Ag Vorhof-selektiv exprimierte Kaliumkanäle
WO2007014347A2 (fr) * 2005-07-27 2007-02-01 The Trustees Of Columbia University In The City Of New York Methode de traitement d'etats pathologiques associes a la phosphorylation du canal task-1

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OGITA H ET AL: "Synthesis and structure-activity relationship of diarylamide derivatives as selective inhibitors of the proliferation of human coronary artery smooth muscle cells", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 11, no. 4, 26 February 2001 (2001-02-26), pages 549 - 551, XP004230056, ISSN: 0960-894X *

Also Published As

Publication number Publication date
WO2008013988A9 (fr) 2008-04-10
EP2068628A2 (fr) 2009-06-17
WO2008013988A3 (fr) 2008-12-18
WO2008013988A2 (fr) 2008-01-31

Similar Documents

Publication Publication Date Title
GB0601961D0 (en) Method
GB0603081D0 (en) Method
EP1987110A4 (fr) Procédé de traitement d'un substrat
GB0607317D0 (en) Method
GB0606147D0 (en) Method
GB0605323D0 (en) Method
GB0603008D0 (en) Method
GB0610468D0 (en) A method of manufacturing a component
GB0604018D0 (en) Method
GB0601699D0 (en) Method
GB0602986D0 (en) Method
GB0620712D0 (en) Method of embssing a substrate
GB0606954D0 (en) Method
GB0612342D0 (en) Method
GB0612014D0 (en) Method
GB0611391D0 (en) Method
EP2068628A4 (fr) Procédé de traitement d'une affection associée a la phosphorylation de task-i
GB0610949D0 (en) Method
GB0617274D0 (en) Method
GB0610338D0 (en) Method
GB0609901D0 (en) Method
GB0602830D0 (en) Method
GB2477448B (en) Method of manufacturing a part having a bore therethrough
HK1132167A1 (en) Method for manufacturing of a urisheath
GB0613833D0 (en) Method of fitting a component

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090225

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20091007

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 9/06 20060101ALI20091001BHEP

Ipc: A61K 31/196 20060101ALI20091001BHEP

Ipc: A61K 31/192 20060101ALI20091001BHEP

Ipc: A61K 31/167 20060101ALI20091001BHEP

Ipc: A61K 31/10 20060101ALI20091001BHEP

Ipc: A61K 31/16 20060101ALI20091001BHEP

Ipc: A01N 37/18 20060101AFI20090303BHEP

17Q First examination report despatched

Effective date: 20100115

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20140407